Stay updated with breaking news from Ocular Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZUG, Switzerland, May 30, 2024 -- Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members...
Following the achievement of two positive key late-stage clinical milestones on its lead product candidate OCS-01 and recent listing on NASDAQ, Oculis is strengthening its executive leadership team with the appointment of Rebecca Weil, Ph.D., seasoned global ophthalmology commercial executive, as Chief Commercial OfficerOCS-01’s recent positive topline results in Phase 3 DIAMOND Stage 1 trial for diabetic macular edema (DME) and in Phase 3 OPTIMIZE trial for inflammation and pain following catar
Ocular Surgery News | We read, with great concern, the recent article regarding workforce challenges in pediatric ophthalmology (Healio/Ocular Surgery News, Jan. 25, 2023, page 1).The article focuses on reimbursement decreases, decline in pediatric ophthalmology fellowship match rates, and access to care for specialized pediatric eye care and strabismus management, but the headline labeling this an “economic
Press Release: Oculis Strengthens its Scientific Advisory Board with World-Leading Ophthalmology Experts to Support Pipeline Development Oculis Strengthens its Scientific Advisory Board with World-Leading
Virtual Webinar to Take Place Friday, October 14th @ 11 AM ET Topline Results from ZETA-1 Phase 2b Trial of APX3330 Expected Later in 4Q 2022 FARMINGTON...